The Chemours Company (NYSE:CC) Receives $30.89 Consensus Target Price from Brokerages

The Chemours Company (NYSE:CC) has earned an average rating of “Hold” from the eight brokerages that are covering the company, Marketbeat.com reports. Six investment analysts have rated the stock with a hold recommendation and two have given a buy recommendation to the company. The average 12 month target price among analysts that have issued ratings on the stock in the last year is $30.89.

Several analysts have commented on the stock. BMO Capital Markets raised shares of Chemours from an “underperform” rating to an “outperform” rating and boosted their target price for the stock from $19.00 to $34.00 in a research report on Tuesday, April 9th. Barclays decreased their target price on shares of Chemours from $32.00 to $30.00 and set an “equal weight” rating for the company in a research report on Tuesday, April 2nd. Finally, UBS Group upped their price objective on shares of Chemours from $21.00 to $28.00 and gave the stock a “neutral” rating in a report on Tuesday, April 2nd.

Institutional Trading of Chemours

Hedge funds have recently bought and sold shares of the stock. CWM LLC raised its stake in shares of Chemours by 41.3% in the third quarter. CWM LLC now owns 3,495 shares of the specialty chemicals company’s stock worth $98,000 after acquiring an additional 1,021 shares during the last quarter. IFP Advisors Inc lifted its position in shares of Chemours by 39.0% in the third quarter. IFP Advisors Inc now owns 2,232 shares of the specialty chemicals company’s stock worth $63,000 after purchasing an additional 626 shares in the last quarter. Avior Wealth Management LLC bought a new stake in Chemours during the third quarter worth $80,000. Richelieu Gestion SA bought a new stake in Chemours during the third quarter worth $2,707,000. Finally, Oak Thistle LLC bought a new stake in Chemours during the third quarter worth $467,000. 76.26% of the stock is owned by institutional investors.

Chemours Stock Down 0.2 %

Chemours stock opened at $27.03 on Tuesday. The firm has a market cap of $4.02 billion, a PE ratio of -17.44 and a beta of 2.00. The company has a debt-to-equity ratio of 5.40, a quick ratio of 1.00 and a current ratio of 1.54. The firm’s 50 day moving average price is $26.73 and its two-hundred day moving average price is $27.80. Chemours has a twelve month low of $15.10 and a twelve month high of $39.05.

Chemours (NYSE:CC) last released its quarterly earnings data on Wednesday, March 27th. The specialty chemicals company reported $0.31 earnings per share for the quarter, beating the consensus estimate of $0.29 by $0.02. The firm had revenue of $1.36 billion for the quarter, compared to analyst estimates of $1.37 billion. Chemours had a negative net margin of 3.80% and a positive return on equity of 51.73%. On average, research analysts predict that Chemours will post 2.23 EPS for the current fiscal year.

Chemours Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, March 15th. Shareholders of record on Monday, February 26th were issued a $0.25 dividend. This represents a $1.00 dividend on an annualized basis and a yield of 3.70%. The ex-dividend date of this dividend was Friday, February 23rd. Chemours’s dividend payout ratio (DPR) is presently -64.52%.

About Chemours

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.